Descrizione Clinica
Bench drugs Macmiror complex cream vag 30g
MACMIROR COMPLEX 10 G/4.000.000 U.I. CREAM
active ingredients
100 g cream contain: nifuratel g 10; nistatina U.I. 4.000.000. For the full list of excipients, see paragraph 6.1.Excellent
100 g of cream contain: xalifin 15; methyl p-hydroxybenzoate; p-hydroxybenzoate propile; glycerine; 70% sorbitol; propylene glycol; carbomer; triethanolamine 30% p/v; deionized water.Therapeutic indications
Polyvalent therapy of vulvovaginal diseases from pathogenic microorganisms: Candida, Trichomonas and bacteria.Contraindications
Hypersensitivity to active ingredients or any of the excipients listed in paragraph 6.1.Population
2.5 g cream, once or twice a day, in the evening and/or in the morning. The necessary dose of cream will be applied with an applicator.Conservation
Nothing to report.Warnings
The use, especially if prolonged, of the product can give rise to phenomena of sensitization. In the case of the appearance of reaction of hypersensitivity the administration of the drug must be interrupted. During treatment refrain from sexual intercourse.Interactions
Pharmacological interactions with MACMIROR COMPLEX components have not been described.Effects
No secondary effect has been described after use of the drug. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.Overdosing
Not to be considered, given the way of administration.There are no contraindications.
Source: Farmadati
